News
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
Word spread quickly online about the change after Caremark ... employer clients paid for obesity drugs by 10% to 15% compared with the previous year. Advertising “CVS Caremark was able to ...
This week, CVS Health said Wegovy will become the preferred option on its standard formulary, or list of covered drugs, as of ...
1d
Zacks Investment Research on MSNLilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...
Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...
Omada Health, a virtual chronic care provider, filed to go public Friday, marking the second digital health company making ...
StockStory.org on MSN1d
LLY Q1 Earnings Call: Revenue Beats Expectations, Profit Guidance Trimmed Amid Price PressuresGlobal pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion.
2d
MedPage Today on MSNCVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers' BankruptcyPeople prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...
They’re among the hottest-selling drugs in the country. But in Massachusetts, as elsewhere in the country, the people who would benefit most from these drugs may not be getting them, according ...
Four states joined a federal lawsuit against CVS Pharmacy that claims the company caused state Medicaid programs to pay higher prices than non-Medicaid payers for prescription drugs. The states ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results